Download PDF
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2020; 24(02): e198-e205
DOI: 10.1055/s-0039-1698775
Original Research
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

An Investigation of Hearing (250–20,000 Hz) in Children with Endocrine Diseases and Evaluation of Tinnitus and Vertigo Symptoms

Murat Kocyigit 
1   Department of Otolaryngolgy, Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, Istanbul, Turkey
,
Selin Ustun Bezgin
1   Department of Otolaryngolgy, Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, Istanbul, Turkey
,
Taliye Cakabay
1   Department of Otolaryngolgy, Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, Istanbul, Turkey
,
Safiye Giran Ortekin
1   Department of Otolaryngolgy, Istanbul Kanuni Sultan Suleyman Egitim ve Arastirma Hastanesi, Istanbul, Turkey
,
Melek Yıldız
2   Department of Pediatric Endocrinology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
,
Guven Ozkaya
3   Department of Biostatistics, Uludag Universitesi Tip Fakultesi, Bursa, Turkey
,
Banu Aydın
2   Department of Pediatric Endocrinology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
› Author Affiliations
Further Information

Publication History

14 March 2019

18 August 2019

Publication Date:
28 January 2020 (online)

   Permissions and Reprints

Abstract

Introduction Despite much advancement in medicine, endocrine and metabolic diseases remain an important cause of morbidity and even mortality in children.

Objective The present study was planned to investigate the evaluation of hearing that also includes high frequencies, and the presence and degree of vertigo and tinnitus symptoms in pediatric patients diagnosed with endocrine diseases such as type 1 diabetes mellitus (DM), growth hormone deficiency (GHD), obesity, idiopathic short stature, and precocious puberty

Methods The present study included a patient group of 207 children patients diagnosed with endocrine disease (95 males, 112 females; mean age 9.71 years old [range 6–16 years old]) and a control group including 55 healthy children who do not have any kind of chronic disease (26 males, 29 females; mean age 9.33 years old [range 6–16 years old]). The subjects underwent a hearing test with frequencies between 250 and 20,000 Hz. The vestibular and tinnitus symptoms were evaluated with the Pediatric Vestibular Symptom Questionnaire.

Results Out of 207 patients in the patient group, 5 (2.4%) had hearing loss in pure tones, 10 (4.8%) had it in high frequencies, 40 (19.3%) had tinnitus symptoms, and 18 (8.7%) had vertigo symptoms. A total of 4 out of 207 patients in the study group (1.9%), 2 out of 59 with type 1 DM patients (3.4%), 1 out of 46 with GHD (2.2%), and 1 out of 43 obesity patients (2.3%) had hearing loss, vertigo, and tinnitus symptoms.

Conclusions Our results suggest that some childhood endocrine diseases can cause some changes in the inner ear, although the exact cause is unknown. Perhaps, a detailed hearing and balance examination should be a routine in a child diagnosed with an endocrine disease. We think it is necessary to work on more comprehensive patient groups and tests in the future.

Keywords

Endocrinology - pediatric - hearing level - tinnitus - vertigo

Compliance with Ethical Standards


Ethics Committee Approval

The study was approved by the Institutional Review Board.


Informed Consent

Informed written consent was obtained from the parents of the children studied after explanation of the purpose of the research.


Research Involving Human Participants and/or Animals

All of the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


Financial Disclosure

The authors declared that this study received no financial support.


 

  • References

  • 1 Maia CAS, Campos CAH. Diabetes mellitus as etiological factor of hearing loss. Rev Bras Otorrinolaringol (Engl Ed) 2005; 71 (02) 208-214
    CrossrefGoogle Scholar
  • 2 Funk JL. Pathopliydi’dogyof diseases. Yavuz A (Çev), 4th Edition. Ankara: Palme Publishing; 2006: 244-251
    PubMedGoogle Scholar
  • 3 Di Nardo W, Ghirlanda G, Paludetti G. , et al. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM. Diabetes Care 1998; 21 (08) 1317-1321
    CrossrefPubMedGoogle Scholar
  • 4 Di Leo MAS, Di Nardo W, Cercone S. , et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 1997; 20 (05) 824-828
    CrossrefPubMedGoogle Scholar
  • 5 Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994; 125 (01) 29-35
    CrossrefPubMedGoogle Scholar
  • 6 Dorigueto RS, Mezzalira R, Serra AP. Semiology of hearing and balance. In: Caldas Neto S, Mello Ju'nior JF, Martins RHG, Costa SS, eds. Tratado de Otorrinolaringologia. Vol I. 2nd ed. São Paulo, Brazil: ed Roca; 2011: 362-79
    Google Scholar
  • 7 Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 2003; 40 (12) 913-917
    CrossrefPubMedGoogle Scholar
  • 8 Walenkamp MJ, Karperien M, Pereira AM. , et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005; 90 (05) 2855-2864
    CrossrefPubMedGoogle Scholar
  • 9 Attias J, Zarchi O, Nageris BI, Laron Z. Cochlear hearing loss in patients with Laron syndrome. Eur Arch Otorhinolaryngol 2012; 269 (02) 461-466
    CrossrefPubMedGoogle Scholar
  • 10 Camarero G, Villar MA, Contreras J. , et al. Cochlear abnormalities in insulin-like growth factor-1 mouse mutants. Hear Res 2002; 170 (1-2): 2-11
    CrossrefPubMedGoogle Scholar
  • 11 Camarero G, Avendano C, Fernandez-Moreno C. , et al. Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice. J Neurosci 2001; 21 (19) 7630-7641
    CrossrefPubMedGoogle Scholar
  • 12 Armstrong CS, Wuarin L, Ishii DN. Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. J Neurosci Res 2000; 59 (05) 649-660
    CrossrefPubMedGoogle Scholar
  • 13 Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307 (05) 483-490
    CrossrefPubMedGoogle Scholar
  • 14 de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004; 110 (16) 2494-2497
    CrossrefPubMedGoogle Scholar
  • 15 Gates GA, Cobb JL, D'Agostino RB, Wolf PA. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 1993; 119 (02) 156-161
    CrossrefPubMedGoogle Scholar
  • 16 Barrenäs ML, Jonsson B, Tuvemo T, Hellström PA, Lundgren M. High risk of sensorineural hearing loss in men born small for gestational age with and without obesity or height catch-up growth: a prospective longitudinal register study on birth size in 245,000 Swedish conscripts. J Clin Endocrinol Metab 2005; 90 (08) 4452-4456
    CrossrefPubMedGoogle Scholar
  • 17 Fransen E, Topsakal V, Hendrickx JJ. , et al. Occupational noise, smoking, and a high body mass index are risk factors for age-related hearing impairment and moderate alcohol consumption is protective: a European population-based multicenter study. J Assoc Res Otolaryngol 2008; 9 (03) 264-276 , discussion 261–263
    CrossrefPubMedGoogle Scholar
  • 18 Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr 2014; 164 (5, Suppl) S1-14.e6
    CrossrefPubMedGoogle Scholar
  • 19 Allen DB, Cuttler L. Clinical practice. Short stature in childhood--challenges and choices. N Engl J Med 2013; 368 (13) 1220-1228
    CrossrefPubMedGoogle Scholar
  • 20 Bierich JR. Sexual precocity. Clin Endocrinol Metab 1975; 4 (01) 107-142
    CrossrefPubMedGoogle Scholar
  • 21 Pavlou M, Whitney S, Alkathiry AA. , et al. The Pediatric Vestibular Symptom Questionnaire: A Validation Study. J Pediatr 2016; 168: 171-7.e1
    CrossrefPubMedGoogle Scholar
  • 22 Vartiainen E, Karjalainen S. Prevalence and etiology of unilateral sensorineural hearing impairment in a Finnish childhood population. Int J Pediatr Otorhinolaryngol 1998; 43 (03) 253-259
    CrossrefPubMedGoogle Scholar
  • 23 Duck SW, Prazma J, Bennett PS, Pillsbury HC. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope 1997; 107 (12 Pt 1): 1596-1605
    CrossrefPubMedGoogle Scholar
  • 24 D'Silva LJ, Lin J, Staecker H, Whitney SL, Kluding PM. Impact of diabetic complications on balance and falls: Contribution of the vestibular system. Phys Ther 2016; 96 (03) 400-409 . DOI: 10.2522/ptj.20140604
    CrossrefPubMedGoogle Scholar
  • 25 Ugur AK, Kemaloglu YK, Ugur MB. , et al. Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children. Int J Pediatr Otorhinolaryngol 2009; 73 (04) 555-559
    CrossrefPubMedGoogle Scholar
  • 26 Gibbin KP, Davis CG. A hearing survey in diabetes mellitus. Clin Otolaryngol Allied Sci 1981; 6 (05) 345-350
    CrossrefPubMedGoogle Scholar
  • 27 Harner SG. Hearing in adult-onset diabetes mellitus. Otolaryngol Head Neck Surg 1981; 89 (02) 322-327
    CrossrefPubMedGoogle Scholar
  • 28 Kovar M. The inner ear in diabetes mellitus. ORL J Otorhinolaryngol Relat Spec 1973; 35 (01) 42-51
    CrossrefPubMedGoogle Scholar
  • 29 Triana RJ, Suits GW, Garrison S. , et al. Inner ear damage secondary to diabetes mellitus. I. Changes in adolescent SHR/N-cp rats. Arch Otolaryngol Head Neck Surg 1991; 117 (06) 635-640
    CrossrefPubMedGoogle Scholar
  • 30 Reske –Nielsen E. Lundback K, Rafaelsen O. Pathological changes in the central and peripheral nervous system of young long-term diabetics. Diabetic encephalopaty. Diabetologia 1965; I: 233-241
    Google Scholar
  • 31 Namyslowski G, Morawski K, Kossowska I, Lisowska G, Koehler B, Jarosz-Chobot P. Contralateral suppression of TUOAE in diabetic children. Effects of 1.0 kHz and 2.0 kHz pure tone stimulation preliminary study. Scand Audiol 2001; 30 (Suppl. 52) 126-129
    Google Scholar
  • 32 Kakarlapudi V, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otol Neurotol 2003; 24 (03) 382-386
    CrossrefPubMedGoogle Scholar
  • 33 Lasisi OA, Nwaorgu OGB, Bella AF. Cochleovestibular complications of diabetes mellitus in Ibadan, Nigeria. Int Congr Ser 2003; 1240: 1325-1328
    CrossrefGoogle Scholar
  • 34 Gibbin KP, Davis CG, Bhanu TS. A hearing survey in diabetes mellitus. Clin Otolaryngol Allied Sci 1981; 6 (05) 345-350
    CrossrefPubMedGoogle Scholar
  • 35 Prado-Barreto VM, Salvatori R, Santos Júnior RC. , et al. Hearing status in adult individuals with lifetime, untreated isolated growth hormone deficiency. Otolaryngol Head Neck Surg 2014; 150 (03) 464-471
    CrossrefPubMedGoogle Scholar
  • 36 Muus JS, Weir FW, Kreicher KL, Bowlby DA, Discolo CM, Meyer TA. Hearing loss in children with growth hormone deficiency. Int J Pediatr Otorhinolaryngol 2017; 100: 107-113
    CrossrefPubMedGoogle Scholar
  • 37 Hwang JH, Hsu CJ, Liu TC, Yang WS. Association of plasma adiponectin levels with hearing thresholds in adults. Clin Endocrinol (Oxf) 2011; 75 (05) 614-620
    CrossrefPubMedGoogle Scholar
  • 38 Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89 (06) 2563-2568
    CrossrefPubMedGoogle Scholar
  • 39 Magge SN, Stettler N, Koren D. , et al. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. J Clin Endocrinol Metab 2011; 96 (05) 1549-1554
    CrossrefPubMedGoogle Scholar
  • 40 Frisina ST, Mapes F, Kim S, Frisina DR, Frisina RD. Characterization of hearing loss in aged type II diabetics. Hear Res 2006; 211 (1-2): 103-113
    CrossrefPubMedGoogle Scholar
  • 41 Evans MB, Tonini R, Shope CD. , et al. Dyslipidemia and auditory function. Otol Neurotol 2006; 27 (05) 609-614
    CrossrefPubMedGoogle Scholar
  • 42 Shargorodsky J, Curhan SG, Eavey R, Curhan GC. A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope 2010; 120 (09) 1887-1891
    CrossrefPubMedGoogle Scholar
  • 43 Hwang JH, Wu CC, Hsu CJ, Liu TC, Yang WS. Association of central obesity with the severity and audiometric configurations of age-related hearing impairment. Obesity (Silver Spring) 2009; 17 (09) 1796-1801
    CrossrefPubMedGoogle Scholar
  • 44 Kılıç K, Sakat MS, Çayır A. Evaluation of Hearing in Children with Metabolic Syndrome. Turk Arch Otorhinolaryngol 2018; 56 (03) 160-165
    CrossrefPubMedGoogle Scholar
  • 45 Bener A, Al-Hamaq AOAA, Abdulhadi K, Salahaldin AH, Gansan L. Interaction between diabetes mellitus and hypertension on risk of hearing loss in highly endogamous population. Diabetes Metab Syndr 2017; 11 (Suppl 1): S45-S51
    CrossrefPubMedGoogle Scholar
  • 46 McGaughran JM, Price DA, Kerr BA. Precocious puberty, endometriosis, skeletal anomalies and mild hearing loss: a new autosomal dominant syndrome?. Clin Dysmorphol 2001; 10 (04) 235-239
    CrossrefPubMedGoogle Scholar
  • 47 Nishi E, Mizuno S, Nanjo Y. , et al. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines. Am J Med Genet A 2015; 167A (02) 407-411
    PubMedGoogle Scholar